-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Matinas BioPharma Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2022 to Q3 2024.
- Matinas BioPharma Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 5.04M shares, a 15.9% increase year-over-year.
- Matinas BioPharma Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 217M shares, a 0.21% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)